Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.14) by 42.86 percent. This is a 72.41 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $39.000 thousand which missed the analyst consensus estimate of $60.000 thousand by 35.00 percent. This is a 15.22 percent decrease over sales of $46.000 thousand the same period last year.